Home › Companies › HERON THERAPEUTICS INC. › 2024-2025
Compiled from SEC Form N-PX filings and HERON THERAPEUTICS INC.’s Form 8-K, filed June 18, 2025 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of June 12, 2025: 8 items on HERON THERAPEUTICS INC.’s Form 8-K, filed June 18, 2025: 2 approved · 6 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore HERON THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are HERON THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 18, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Mr. Collard | 82,777,195 | 1,274,608 | 47,119 | -- | 35,904,582 | 98% | Not verified | — |
| Elect Director: Dr. Dissanaike | 81,364,822 | 2,625,421 | 108,679 | -- | 35,904,582 | 97% | Not verified | — |
| Elect Director: Mr. Johnson | 81,742,495 | 2,302,736 | 53,691 | -- | 35,904,582 | 97% | Not verified | — |
| Elect Director: Mr. Kaseta | 81,849,779 | 2,202,021 | 47,122 | -- | 35,904,582 | 97% | Not verified | — |
| Elect Director: Mr. Morgan | 82,815,802 | 1,225,808 | 57,312 | -- | 35,904,582 | 99% | Not verified | — |
| Elect Director: Mr. Waage | 79,359,803 | 4,687,202 | 51,917 | -- | 35,904,582 | 94% | Not verified | — |
| 2. The appointment of Withum Smith+Brown, PC as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 | 118,578,049 | 1,033,191 | 392,264 | -- | 0 | 99.1% | Approved | — |
| 3. On a nonbinding advisory basis, the compensation paid to the Company's Named Executive Officers during the fiscal year ended December 31, 2024 | 79,260,872 | 3,528,575 | 1,309,475 | -- | 35,904,582 | 96% | Approved | — |
Source: HERON THERAPEUTICS INC., Form 8-K, filed with the SEC on June 18, 2025 — read the filing on EDGAR.
Each item below shows how the 151 asset managers that disclosed a HERON THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of HERON THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 2 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: To elect six director nominees to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Adam Morgan
HERON THERAPEUTICS INC.’s own tally for this item (“Elect Director: Mr. Morgan”): 82,815,802 for, 1,225,808 against, per its Form 8-K filed June 18, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 39 asset managers below reported 10,441,405 for, 11,502 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 2,451,439 | 0 | 0 | 0 | For |
| Vanguard | 2,288,078 | 0 | 0 | 0 | For |
| BlackRock | 2,224,509 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 677,391 | 0 | 0 | 0 | For |
| State Street | 589,379 | 0 | 0 | 0 | For |
| Charles Schwab | 430,963 | 0 | 0 | 0 | For |
| Equitable | 370,043 | 0 | 0 | 0 | For |
| Goldman Sachs | 259,932 | 0 | 0 | 0 | For |
| HIGHLAND GLOBAL ALLOCATION FUND | 232,800 | 0 | 0 | 0 | For |
| Lincoln Financial | 161,639 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 109,681 | 0 | 0 | 0 | For |
| Nationwide | 100,663 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 59,972 | 0 | 0 | 0 | For |
| Pacific Life | 53,855 | 0 | 0 | 0 | For |
| Northern Trust | 51,094 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 50,518 | 0 | 0 | 0 | For |
| Fidelity | 47,375 | 0 | 0 | 0 | For |
| John Hancock | 44,152 | 0 | 0 | 0 | For |
| Voya | 29,992 | 0 | 0 | 0 | For |
| Invesco | 25,593 | 0 | 0 | 0 | For |
| Brighthouse | 24,515 | 0 | 0 | 0 | For |
| ProShares | 23,438 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 22,992 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 21,878 | 0 | 0 | 0 | For |
| SEI | 20,900 | 0 | 0 | 0 | For |
Showing the 25 largest of 39 asset managers. See all 39 in the interactive database.
Combines 2 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: To elect six director nominees to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Christian Waage
HERON THERAPEUTICS INC.’s own tally for this item (“Elect Director: Mr. Waage”): 79,359,803 for, 4,687,202 against, per its Form 8-K filed June 18, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 39 asset managers below reported 9,882,431 for, 570,476 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 2,451,439 | 0 | 0 | 0 | For |
| Vanguard | 2,288,078 | 0 | 0 | 0 | For |
| BlackRock | 2,224,509 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 677,391 | 0 | 0 | 0 | For |
| State Street | 581,587 | 7,792 | 0 | 0 | For |
| Charles Schwab | 0 | 430,963 | 0 | 0 | Against |
| Equitable | 370,043 | 0 | 0 | 0 | For |
| Goldman Sachs | 259,932 | 0 | 0 | 0 | For |
| HIGHLAND GLOBAL ALLOCATION FUND | 232,800 | 0 | 0 | 0 | For |
| Lincoln Financial | 77,347 | 84,292 | 0 | 0 | Mixed |
| Principal Exchange-Traded Funds | 109,681 | 0 | 0 | 0 | For |
| Nationwide | 100,663 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 59,972 | 0 | 0 | 0 | For |
| Pacific Life | 53,855 | 0 | 0 | 0 | For |
| Northern Trust | 51,094 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 50,518 | 0 | 0 | 0 | For |
| Fidelity | 47,375 | 0 | 0 | 0 | For |
| John Hancock | 44,152 | 0 | 0 | 0 | For |
| Voya | 29,992 | 0 | 0 | 0 | For |
| Invesco | 25,593 | 0 | 0 | 0 | For |
| Brighthouse | 24,515 | 0 | 0 | 0 | For |
| ProShares | 23,438 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 0 | 22,992 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 21,878 | 0 | 0 | 0 | For |
| SEI | 20,900 | 0 | 0 | 0 | For |
Showing the 25 largest of 39 asset managers. See all 39 in the interactive database.
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: To elect six director nominees to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Craig Collard
HERON THERAPEUTICS INC.’s own tally for this item (“Elect Director: Mr. Collard”): 82,777,195 for, 1,274,608 against, per its Form 8-K filed June 18, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 39 asset managers below reported 10,452,907 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 2,451,439 | 0 | 0 | 0 | For |
| Vanguard | 2,288,078 | 0 | 0 | 0 | For |
| BlackRock | 2,224,509 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 677,391 | 0 | 0 | 0 | For |
| State Street | 589,379 | 0 | 0 | 0 | For |
| Charles Schwab | 430,963 | 0 | 0 | 0 | For |
| Equitable | 370,043 | 0 | 0 | 0 | For |
| Goldman Sachs | 259,932 | 0 | 0 | 0 | For |
| HIGHLAND GLOBAL ALLOCATION FUND | 232,800 | 0 | 0 | 0 | For |
| Lincoln Financial | 161,639 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 109,681 | 0 | 0 | 0 | For |
| Nationwide | 100,663 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 59,972 | 0 | 0 | 0 | For |
| Pacific Life | 53,855 | 0 | 0 | 0 | For |
| Northern Trust | 51,094 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 50,518 | 0 | 0 | 0 | For |
| Fidelity | 47,375 | 0 | 0 | 0 | For |
| John Hancock | 44,152 | 0 | 0 | 0 | For |
| Voya | 29,992 | 0 | 0 | 0 | For |
| Invesco | 25,593 | 0 | 0 | 0 | For |
| Brighthouse | 24,515 | 0 | 0 | 0 | For |
| ProShares | 23,438 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 22,992 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 21,878 | 0 | 0 | 0 | For |
| SEI | 20,900 | 0 | 0 | 0 | For |
Showing the 25 largest of 39 asset managers. See all 39 in the interactive database.
Combines 2 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: To elect six director nominees to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Craig Johnson
HERON THERAPEUTICS INC.’s own tally for this item (“Elect Director: Mr. Johnson”): 81,742,495 for, 2,302,736 against, per its Form 8-K filed June 18, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 39 asset managers below reported 10,451,174 for, 1,733 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 2,451,439 | 0 | 0 | 0 | For |
| Vanguard | 2,288,078 | 0 | 0 | 0 | For |
| BlackRock | 2,224,509 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 677,391 | 0 | 0 | 0 | For |
| State Street | 589,379 | 0 | 0 | 0 | For |
| Charles Schwab | 430,963 | 0 | 0 | 0 | For |
| Equitable | 370,043 | 0 | 0 | 0 | For |
| Goldman Sachs | 259,932 | 0 | 0 | 0 | For |
| HIGHLAND GLOBAL ALLOCATION FUND | 232,800 | 0 | 0 | 0 | For |
| Lincoln Financial | 161,639 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 109,681 | 0 | 0 | 0 | For |
| Nationwide | 100,663 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 59,972 | 0 | 0 | 0 | For |
| Pacific Life | 53,855 | 0 | 0 | 0 | For |
| Northern Trust | 51,094 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 50,518 | 0 | 0 | 0 | For |
| Fidelity | 47,375 | 0 | 0 | 0 | For |
| John Hancock | 44,152 | 0 | 0 | 0 | For |
| Voya | 29,992 | 0 | 0 | 0 | For |
| Invesco | 25,593 | 0 | 0 | 0 | For |
| Brighthouse | 24,515 | 0 | 0 | 0 | For |
| ProShares | 23,438 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 22,992 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 21,878 | 0 | 0 | 0 | For |
| SEI | 20,900 | 0 | 0 | 0 | For |
Showing the 25 largest of 39 asset managers. See all 39 in the interactive database.
Combines 2 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: To elect six director nominees to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Michael Kaseta
HERON THERAPEUTICS INC.’s own tally for this item (“Elect Director: Mr. Kaseta”): 81,849,779 for, 2,202,021 against, per its Form 8-K filed June 18, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 39 asset managers below reported 10,452,907 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 2,451,439 | 0 | 0 | 0 | For |
| Vanguard | 2,288,078 | 0 | 0 | 0 | For |
| BlackRock | 2,224,509 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 677,391 | 0 | 0 | 0 | For |
| State Street | 589,379 | 0 | 0 | 0 | For |
| Charles Schwab | 430,963 | 0 | 0 | 0 | For |
| Equitable | 370,043 | 0 | 0 | 0 | For |
| Goldman Sachs | 259,932 | 0 | 0 | 0 | For |
| HIGHLAND GLOBAL ALLOCATION FUND | 232,800 | 0 | 0 | 0 | For |
| Lincoln Financial | 161,639 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 109,681 | 0 | 0 | 0 | For |
| Nationwide | 100,663 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 59,972 | 0 | 0 | 0 | For |
| Pacific Life | 53,855 | 0 | 0 | 0 | For |
| Northern Trust | 51,094 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 50,518 | 0 | 0 | 0 | For |
| Fidelity | 47,375 | 0 | 0 | 0 | For |
| John Hancock | 44,152 | 0 | 0 | 0 | For |
| Voya | 29,992 | 0 | 0 | 0 | For |
| Invesco | 25,593 | 0 | 0 | 0 | For |
| Brighthouse | 24,515 | 0 | 0 | 0 | For |
| ProShares | 23,438 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 22,992 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 21,878 | 0 | 0 | 0 | For |
| SEI | 20,900 | 0 | 0 | 0 | For |
Showing the 25 largest of 39 asset managers. See all 39 in the interactive database.
Combines 2 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: To elect six director nominees to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Sharmila Dissanaike, M.D., FACS, FCCM
HERON THERAPEUTICS INC.’s own tally for this item (“Elect Director: Dr. Dissanaike”): 81,364,822 for, 2,625,421 against, per its Form 8-K filed June 18, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 39 asset managers below reported 10,415,395 for, 37,512 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 2,451,439 | 0 | 0 | 0 | For |
| Vanguard | 2,288,078 | 0 | 0 | 0 | For |
| BlackRock | 2,224,509 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 677,391 | 0 | 0 | 0 | For |
| State Street | 589,379 | 0 | 0 | 0 | For |
| Charles Schwab | 430,963 | 0 | 0 | 0 | For |
| Equitable | 370,043 | 0 | 0 | 0 | For |
| Goldman Sachs | 259,932 | 0 | 0 | 0 | For |
| HIGHLAND GLOBAL ALLOCATION FUND | 232,800 | 0 | 0 | 0 | For |
| Lincoln Financial | 161,639 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 109,681 | 0 | 0 | 0 | For |
| Nationwide | 100,663 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 59,972 | 0 | 0 | 0 | For |
| Pacific Life | 53,855 | 0 | 0 | 0 | For |
| Northern Trust | 51,094 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 50,518 | 0 | 0 | 0 | For |
| Fidelity | 47,375 | 0 | 0 | 0 | For |
| John Hancock | 44,152 | 0 | 0 | 0 | For |
| Voya | 29,992 | 0 | 0 | 0 | For |
| Invesco | 25,593 | 0 | 0 | 0 | For |
| Brighthouse | 24,515 | 0 | 0 | 0 | For |
| ProShares | 23,438 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 0 | 22,992 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 21,878 | 0 | 0 | 0 | For |
| SEI | 20,900 | 0 | 0 | 0 | For |
Showing the 25 largest of 39 asset managers. See all 39 in the interactive database.
Combines 6 wordings of this item as funds reported it.
96% Approved · of votes cast
Description as filed by funds: To approve, on a nonbinding advisory basis, compensation paid to our Named Executive Officers for the fiscal year ended December 31, 2024.
HERON THERAPEUTICS INC.’s own tally for this item (“3. On a nonbinding advisory basis, the compensation paid to the Company's Named Executive Officers during the fiscal year ended December 31, 2024”): 79,260,872 for, 3,528,575 against — passed, per its Form 8-K filed June 18, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3: The Company's stockholders approved, on a nonbinding advisory basis, the compensation paid to the Company's Named Executive Officers during the fiscal year ended December 31, 2024:”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 2,451,439 | 0 | 0 | 0 | For |
| Vanguard | 2,288,078 | 0 | 0 | 0 | For |
| BlackRock | 2,224,509 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 677,391 | 0 | 0 | 0 | For |
| State Street | 589,379 | 0 | 0 | 0 | For |
| Charles Schwab | 430,963 | 0 | 0 | 0 | For |
| Equitable | 370,043 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 259,932 | 0 | 0 | Against |
| HIGHLAND GLOBAL ALLOCATION FUND | 232,800 | 0 | 0 | 0 | For |
| Lincoln Financial | 161,639 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 109,681 | 0 | 0 | 0 | For |
| Nationwide | 12,624 | 88,039 | 0 | 0 | Mixed |
| AIG/SunAmerica | 59,972 | 0 | 0 | 0 | For |
| Pacific Life | 53,855 | 0 | 0 | 0 | For |
| Northern Trust | 51,094 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 50,518 | 0 | 0 | 0 | For |
| Fidelity | 47,375 | 0 | 0 | 0 | For |
| John Hancock | 44,152 | 0 | 0 | 0 | For |
| Voya | 29,992 | 0 | 0 | 0 | For |
| Invesco | 25,593 | 0 | 0 | 0 | For |
| Brighthouse | 24,515 | 0 | 0 | 0 | For |
| ProShares | 23,438 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 22,992 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 21,878 | 0 | 0 | 0 | For |
| SEI | 20,900 | 0 | 0 | 0 | For |
Fund voting reports, all 39 managers: 10,104,026 for, 348,881 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Rubric Capital Management LP | 26,451,914 | 0 | 0 | 0 | For |
| Velan Capital Investment Management LP | 6,985,744 | 0 | 0 | 0 | For |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 6,637,616 | 0 | 0 | 0 | For |
| Point72 | 4,575,757 | 0 | 0 | 0 | For |
| PALISADE CAPITAL MANAGEMENT, LP | 3,042,656 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,038,387 | 0 | 0 | 0 | For |
| DE Shaw | 1,882,136 | 0 | 0 | 0 | For |
| NEW YORK STATE COMMON RETIREMENT FUND | 1,760,045 | 0 | 0 | 0 | For |
| BlackRock | 1,338,573 | 0 | 0 | 0 | For |
| State Street | 1,287,965 | 0 | 0 | 0 | For |
| Renaissance | 1,167,737 | 0 | 0 | 0 | For |
| Clearline Capital LP | 1,059,911 | 0 | 0 | 0 | For |
| Orchard Capital Management, LLC | 1,007,846 | 0 | 0 | 0 | For |
| Stonepine Capital Management, LLC | 796,100 | 0 | 0 | 0 | For |
| Two Sigma | 720,435 | 0 | 0 | 0 | For |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 677,391 | 0 | 0 | 0 | For |
| Citadel | 577,574 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 562,493 | 0 | 0 | 0 | For |
| Northern Trust | 521,628 | 0 | 0 | 0 | For |
| Charles Schwab | 430,963 | 0 | 0 | 0 | For |
| Wellington | 354,473 | 0 | 0 | 0 | For |
| NexPoint Advisors, L.P. | 242,950 | 0 | 0 | 0 | For |
| NEXPOINT ASSET MANAGEMENT, L.P. | 232,800 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 219,637 | 0 | 0 | Against |
| AllianceBernstein | 198,550 | 0 | 0 | 0 | For |
Institutional-manager reports, all 125 managers: 67,202,215 for, 250,444 against, 39,401 1 year. Showing the 25 largest; see all in the interactive database.
Combines 5 wordings of this item as funds reported it.
100% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: TO APPROVE, ON A NONBINDING ADVISORY BASIS, THE FREQUENCY OF FUTURE ADVISORY VOTES ON THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| HIGHLAND GLOBAL ALLOCATION FUND | 0 | 0 | 0 | 0 | -- |
| Lincoln Financial | 77,347 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 0 | 0 | 0 | 0 | -- |
| Nationwide | 0 | 0 | 0 | 0 | -- |
| AIG/SunAmerica | 0 | 0 | 0 | 0 | -- |
| Pacific Life | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Bridge Builder Trust | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| John Hancock | 0 | 0 | 0 | 0 | -- |
| Voya | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| Brighthouse | 0 | 0 | 0 | 0 | -- |
| ProShares | 0 | 0 | 0 | 0 | -- |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 0 | 0 | -- |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 0 | -- |
| SEI | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 39 managers: 77,347 for, 10,375,560 1 year. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Rubric Capital Management LP | 0 | 0 | 0 | 0 | -- |
| Velan Capital Investment Management LP | 0 | 0 | 0 | 0 | -- |
| Point72 | 0 | 0 | 0 | 0 | -- |
| PALISADE CAPITAL MANAGEMENT, LP | 0 | 0 | 0 | 0 | -- |
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| DE Shaw | 0 | 0 | 0 | 0 | -- |
| NEW YORK STATE COMMON RETIREMENT FUND | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Renaissance | 0 | 0 | 0 | 0 | -- |
| Clearline Capital LP | 0 | 0 | 0 | 0 | -- |
| Two Sigma | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Citadel | 0 | 0 | 0 | 0 | -- |
| MARSHALL WACE, LLP | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Wellington | 0 | 0 | 0 | 0 | -- |
| NexPoint Advisors, L.P. | 0 | 0 | 0 | 0 | -- |
| NEXPOINT ASSET MANAGEMENT, L.P. | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| AllianceBernstein | 0 | 0 | 0 | 0 | -- |
| MELLON INVESTMENTS Corp | 0 | 0 | 0 | 0 | -- |
| Informed Momentum Co LLC | 0 | 0 | 0 | 0 | -- |
| PRINCIPAL GLOBAL INVESTORS | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 119 managers: 39,401 for, 58,834,066 1 year, 875 3 year. Showing the 25 largest; see all in the interactive database.
99.1% Approved · of votes cast
Description as filed by funds: TO RATIFY THE APPOINTMENT OF WITHUM AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.
HERON THERAPEUTICS INC.’s own tally for this item (“2. The appointment of Withum Smith+Brown, PC as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025”): 118,578,049 for, 1,033,191 against — passed, per its Form 8-K filed June 18, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2: The Company's stockholders ratified the appointment of Withum Smith+Brown, PC as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025:”
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 39 asset managers below reported 10,452,907 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 2,451,439 | 0 | 0 | 0 | For |
| Vanguard | 2,288,078 | 0 | 0 | 0 | For |
| BlackRock | 2,224,509 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 677,391 | 0 | 0 | 0 | For |
| State Street | 589,379 | 0 | 0 | 0 | For |
| Charles Schwab | 430,963 | 0 | 0 | 0 | For |
| Equitable | 370,043 | 0 | 0 | 0 | For |
| Goldman Sachs | 259,932 | 0 | 0 | 0 | For |
| HIGHLAND GLOBAL ALLOCATION FUND | 232,800 | 0 | 0 | 0 | For |
| Lincoln Financial | 161,639 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 109,681 | 0 | 0 | 0 | For |
| Nationwide | 100,663 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 59,972 | 0 | 0 | 0 | For |
| Pacific Life | 53,855 | 0 | 0 | 0 | For |
| Northern Trust | 51,094 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 50,518 | 0 | 0 | 0 | For |
| Fidelity | 47,375 | 0 | 0 | 0 | For |
| John Hancock | 44,152 | 0 | 0 | 0 | For |
| Voya | 29,992 | 0 | 0 | 0 | For |
| Invesco | 25,593 | 0 | 0 | 0 | For |
| Brighthouse | 24,515 | 0 | 0 | 0 | For |
| ProShares | 23,438 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 22,992 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 21,878 | 0 | 0 | 0 | For |
| SEI | 20,900 | 0 | 0 | 0 | For |
Showing the 25 largest of 39 asset managers. See all 39 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 152,563,634 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | T. Rowe Price | 1.61% |
| 2 | Vanguard | 1.50% |
| 3 | BlackRock | 1.46% |
| 4 | BRIDGEWAY FUNDS INC | 0.44% |
| 5 | State Street | 0.39% |
| 6 | Charles Schwab | 0.28% |
| 7 | Equitable | 0.24% |
| 8 | Goldman Sachs | 0.17% |
| 9 | HIGHLAND GLOBAL ALLOCATION FUND | 0.15% |
| 10 | Lincoln Financial | 0.11% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Rubric Capital Management LP | 17.34% |
| 2 | Velan Capital Investment Management LP | 4.58% |
| 3 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.35% |
| 4 | Point72 | 3.00% |
| 5 | PALISADE CAPITAL MANAGEMENT, LP | 1.99% |
| 6 | T. Rowe Price | 1.99% |
| 7 | DE Shaw | 1.23% |
| 8 | NEW YORK STATE COMMON RETIREMENT FUND | 1.15% |
| 9 | BlackRock | 0.88% |
| 10 | State Street | 0.84% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 5.61% | 13F |
| Vanguard Group | 5.39% | 13F |
| Point72 | 3.13% | 13F |
| State Street | 2.13% | 13F |
| Geode Capital | 2.04% | 13F |
| T. Rowe Price | 1.97% | 13F |
| D.E. Shaw | 1.96% | 13F |
| Renaissance Technologies | 1.49% | 13F |
| Morgan Stanley | 1.27% | 13F |
| Millennium Management | 0.91% | 13F |
Percentages above are of 152,563,634 shares outstanding, as reported by HERON THERAPEUTICS INC. on its Form 10-Q dated May 1, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from HERON THERAPEUTICS INC.’s 10-Q dated May 1, 2025. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At HERON THERAPEUTICS INC.'s shareholder meeting held June 12, 2025, in the 2024-2025 proxy season, 151 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,362 separate fund positions. Their filings are grouped here into 9 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on a nonbinding advisory basis, compensation paid to our Named Executive Officers… — HERON THERAPEUTICS INC.'s filing reports the proposal as approved, with 96% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: HERON THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 18, 2025.
HERON THERAPEUTICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.